Pancreatic Cancer Research

ResearcherAmsterdam University Medical CentersActive in the last 2 years

José Annelie Suurmeijer

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2972-5622; OpenAlex author ID A5061483328. Sources: OpenAlex.

Their work

Papers
5 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
47
Papers, trials and grants by year

2022: 3 papers · 2023: 1 paper · 2024: 1 paper

Papers 5

  1. Preoperative chemoradiotherapy but not chemotherapy is associated with reduced risk of postoperative pancreatic fistula after pancreatoduodenectomy for pancrea… First author DOI 10.1016/j.surg.2024.01.029↗
  2. Outcome of Pancreatic Surgery During the First 6 Years of a Mandatory Audit Within the Dutch Pancreatic Cancer Group. Co-author DOI 10.1097/sla.0000000000005628↗
  3. Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients With Resectable or Borderline Resectable Disease (COMM-PACT-RB): A Syst… First author DOI 10.1001/jamaoncol.2022.0168↗
  4. Is the Delphi's Oracle Pertinent to Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma?-Reply. Co-author DOI 10.1001/jamaoncol.2022.4676↗
  5. Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS-2 multicentre study. Co-author DOI 10.1093/bjs/znac272↗

Closest collaborators

The 25 strongest of 47 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marc G. Besselink · 5 shared papers, 2022–2024 · strength 0.78
  2. Hanneke W.M. van Laarhoven · 3 shared papers, 2022 · strength 0.49
  3. Izaak Quintus Molenaar · 3 shared papers, 2022–2024 · strength 0.40
  4. Bert A. Bonsing · 3 shared papers, 2022–2024 · strength 0.40
  5. Johanna W. Wilmink · 3 shared papers, 2022–2024 · strength 0.40
  6. Bas Groot Koerkamp · 3 shared papers, 2022–2024 · strength 0.40
  7. Casper H.J. van Eijck · 3 shared papers, 2022–2024 · strength 0.40
  8. Gijs A. Patijn · 2 shared papers, 2023–2024 · strength 0.29
  9. Martijn Intven · 2 shared papers, 2023–2024 · strength 0.29
  10. Vincent Erwin de Meijer · 2 shared papers, 2023–2024 · strength 0.29
  11. Ignace H. J. T. de Hingh · 2 shared papers, 2023–2024 · strength 0.29
  12. Hjalmar C. van Santvoort · 2 shared papers, 2023–2024 · strength 0.29
  13. Martijn W.J. Stommel · 2 shared papers, 2023–2024 · strength 0.29
  14. Geertjan van Tienhoven · 2 shared papers, 2022–2024 · strength 0.27
  15. Marcel den Dulk · 1 shared paper, 2024 · strength 0.16
  16. Leonoor V. Wismans · 1 shared paper, 2024 · strength 0.16
  17. Sebastiaan Festen · 1 shared paper, 2024 · strength 0.16
  18. Jelle C. van Dongen · 1 shared paper, 2024 · strength 0.16
  19. Judith de Vos‐Geelen · 1 shared paper, 2024 · strength 0.16
  20. Joost J.M.E. Nuyttens · 1 shared paper, 2024 · strength 0.16
  21. Anne Claire Henry · 1 shared paper, 2023 · strength 0.13
  22. Geert Kazemier M · 1 shared paper, 2023 · strength 0.13
  23. Hans Morreau · 1 shared paper, 2022 · strength 0.12
  24. Mark P.G. Dings · 1 shared paper, 2022 · strength 0.12
  25. Jesse V. Groen · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.